One-time items swing Charles River to 3Q loss Nov 8, 2006
The decision came less than two years after Charles River absorbed the phase II-IV operations through its acquisition of clinical research organization Inveresk Research Group for $1. 5 billion in stock. (Triangle Business Journal)
Triangle firms take 33 spots in Technology Fast 50 Jun 30, 2006
Cary: A4 Health Systems, Arsenal Digital, Coventor, Inveresk Research Group, SpectraSite, Transoft, Ultimus. Chapel Hill: Emergys Corp.. (Triangle Business Journal)
Charles River Keeps on Rolling Jun 28, 2005
As part of its purchase of Inveresk Research Group in October, 2004, the company also acquired a clinic to conduct European Phase I drug trials and an established international operation to manage Phase II-IV studies. FINE FIT. We believe Inveresk is a good strategic fit for Charles River. (BusinessWeek)
Charles River Laboratories Announces Strong First-Quarter 2005 Results May 4, 2005
The increase was due primarily to the acquisition of Inveresk Research Group, and also to continuing strong demand for research models and outsourced preclinical services ... Those risks and uncertainties include, but are not limited to: challenges arising from the acquisition of Inveresk Research Group; a decrease in research and development spending or a decrease in the level of outsourced services; acquisition integration risks; the ability to convert backlog to sales; special interest... (Yahoo Finance -- Business Services)
[external] Charles River Labs reaffirms Q1 outlook Mar 31, 2005
BOSTON (MarketWatch) - Charles River Laboratories reaffirmed its first-quarter 2005 financial outlook on Wednesday, stating it expects sales to increase by as much as 60 percent due to its recent merger with Inveresk Research Group. Free. (Yahoo Finance -- Business Services)
[external] Charles River Q4 profit slips on merger costs Feb 15, 2005
SAN FRANCISCO (MarketWatch) -- Charles River Laboratories International Inc. said late Monday that its fourth-quarter net earnings slipped primarily on costs connected to its purchase of Inveresk Research Group. Free. (Yahoo Finance -- Business Services)
Charles River Labs Cautious on 2005 Dec 15, 2004
Charles River Labs lowered guidance for 2005 after amortization costs associated with its acquisition of Inveresk Research Group Inc. were revised upward. In July, the company agreed to pay $1. (SmartMoney)
Charles River Labs shuffles execs, will close Worcester unit Dec 9, 2004
5 billion purchase of Inveresk Research Group in a bid to expand its product testing for drug makers, expanding its reach to that company's North Carolina and Scottish base. The company also announced Wednesday that it had hired Nancy Gillett as a senior vice president and president of its global pre-clinical services division. (Boston Business Journal, MA)
Protox Retains Leading Research Organization for Next Phase of Preclinical Trials Aug 17, 2004
Quick search by organization. " ABOUT PROTOX: Protox Therapeutics Inc. is an early stage biotechnology company focused on developing a pipeline of "smart" drugs for the treatment of cancer. The Company's proprietary technology genetically engineers the naturally occurring protein Aerolysin to target specific cancer cells. The engineered protein is being designed to form "holes" in the membrane of these cells causing them to die. A unique property of this technology is expected to be its... (Canada Newswire)
Higher expenses result in lower Inveresk earnings Jul 29, 2004
Increased expenses caused Cary-based Inveresk Research Group Inc. to report 2004 second-quarter net income of $7. 8 million on Wednesday - a 23 percent drop compared to the $10. (Raleigh Triangle Business Journal, NC)
Bay State biotechs flex muscle in spate of $1B+ merger deals Jul 14, 2004
Charles River Laboratories International Inc. of Wilmington announced last week it would buy Inveresk Research Group Inc. in North Carolina in a $1. 5 billion cash-and-stock deal. (Boston Business Journal, MA)
[external] Charles River Labs to buy Inveresk for $1.5 billion Jul 2, 2004
BOSTON (CBS.MW) -- Charles River Laboratories said Thursday that it plans to buy Inveresk Research Group for $1. 5 billion in stock and cash, a move that triggered a significant sell-off in Charles River's shares. (Yahoo Finance -- Business Services)
Charles River Labs to buy Inveresk for $1.5 billion Jul 2, 2004
Charles River Laboratories International Inc. said it will buy Inveresk Research Group Inc. for about $1. 5 billion in a cash-and-stock deal that the company expects will expand its product testing for drugmakers. (Boston Business Journal, MA)
Boston Herald Jul 2, 2004
The Wilmington company, which caters to drug and medical-device makers, is buying Inveresk Research Group Inc., of Cary, N.C., under the cash-and-stock deal. It allows the company to add clinical testing to its long list of services. (Google News -- Business)
[external] Inveresk jumps on merger news; Barr Labs higher Jul 2, 2004
BOSTON (CBS.MW) -- Shares of Inveresk Research Group jumped more than 14 percent Thursday following Charles River Laboratories' agreement to buy the company for $1. 5 billion in stock and cash. (Yahoo Finance -- Biotechnology & Drugs)
Investor's Business Daily (subscription) Jul 1, 2004
NEW YORK (CBS.MW) -- Charles River Laboratories said Thursday it would buy Inveresk Research Group for $1. 5 billion in stock and cash. (Google News -- Business)
Inveresk hires chief medical officer May 12, 2004
Cary-based clinical research organization Inveresk Research Group has hired Dr. Brian Dickson as the company's chief medical officer. Dickson will oversee all of Inveresk's medical, safety and regulatory operations. (Triangle Business Journal)
Inveresk Research "outperform" May 10, 2004
NEW YORK, May 10 (New Ratings) - Analysts at Robert W Baird reiterate their outperform rating on Inveresk Research Group Inc (). The target price is set to $37. (New Ratings)
Healthcare Technology Report May 8, 2004
Firms interviewed include: Allscripts Healthcare Solutions, Cytomyx Holdings PLC, Endologix, Inveresk Research Group, MIM Corporation, Omnicell, Ophthalmic Imaging Systems, ProxyMed, PSS World Medical and Transcend Services. ORDER THIS REPORT NOW. (The Wall Street Transcript)
Inveresk beats estimates; raises guidance May 5, 2004
Inveresk Research Group Inc. had a double dose of good news for investors Tuesday as the Cary-based company reported earnings that beat analysts' estimates and the firm announced that it had increased its 2004 earnings guidance. The company posted 2004 first quarter net income of $12. (Raleigh Triangle Business Journal, NC)
TABLE-Inveresk Research Group <IRGI.O> Q1 results May 5, 2004
(REUTERS DATA) May 4 - Inveresk Research Group, Inc. Condensed Consolidated Statements of Operations ($ in thousands, except per share and share data) (Unaudited) Qtr Qtr Ended Ended Mar 31, Mar 31, 2004 2003 Net service revenue 76,738 57,684 Direct costs excluding depreciation (39,921) (29,278) 36,817 28,406 Selling, general and administrative expenses: Share offering expenses (306) (658) Other selling, general and administrative expenses (19,853) (16,228) Total selling, general and... (Forbes)
Principal Inveresk stockholder to sell 5M shares Apr 1, 2004
Inveresk Research Group Inc. said Thursday that its principal stockholder has agreed to sell 5 million shares of Inveresk common stock for $133. 75 million. (Triangle Business Journal)
September 16, 2003 issue (dig091603.txt) Jan 22, 2004
15) (BR. ) S-3 INVERESK RESEARCH GROUP INC, 11000 WESTON PARKWAY, SUITE 100, CARY, NC, 27513, 9194609005 - 0 ($222,720,000.00) Equity, (File 333-108813 - Sep. (U.S. Securities and Exchange Commission -- Digest)
November 28, 2003 issue (dig112803.txt) Jan 22, 2004
STATE 8K ITEM NO. NAME OF ISSUER CODE 1 2 3 4 5 6 7 8 9 10 11 12 13 DATE COMMENT ------------------------------------------------------------------------------------------------ 4 KIDS ENTERTAINMENT INC NY X X 11/24/03 ADVANCED BIOTHERAPY INC DE X X 11/24/03 ADVANT E CORP DE X 11/24/03 AEROSONIC CORP /DE/ DE X X 11/21/03 AGWAY INC DE X X 10/25/03 ALCAN INC A6 X 11/25/03 ALLIED HEALTHCARE INTERNATIONAL INC NY X 11/25/03 ALTERNATIVE RESOURCES CORP DE X X 11/25/03 AMERICAN ECOLOGY CORP DE X... (U.S. Securities and Exchange Commission -- Digest)
October 30, 2003 issue (dig103003.txt) Jan 22, 2004
STATE 8K ITEM NO. NAME OF ISSUER CODE 1 2 3 4 5 6 7 8 9 10 11 12 13 DATE COMMENT ------------------------------------------------------------------------------------------------ 1ST CONSTITUTION BANCORP NJ X 10/20/03 AARON RENTS INC GA X X 10/28/03 ABGENIX INC DE X X 10/29/03 ABN AMRO MORT CORP MULTI-CLASS MORT P DE X 10/01/03 ABN AMRO MORTGAGE CORP MORT PS THR CR DE X 10/01/03 ABN AMRO MORTGAGE CORP MUILTI CL MORT DE X 10/01/03 ABN AMRO MORTGAGE CORP MUL CL MORT PA DE X 10/01/03 ABN AMRO... (U.S. Securities and Exchange Commission -- Digest)
October 31, 2003 issue (dig103103.txt) Jan 22, 2004
STATE 8K ITEM NO. NAME OF ISSUER CODE 1 2 3 4 5 6 7 8 9 10 11 12 13 DATE COMMENT ------------------------------------------------------------------------------------------------ 1ST SOURCE CORP IN X X 09/30/03 724 SOLUTIONS INC X X 10/29/03 8X8 INC /DE/ DE X X 10/30/03 ABIOMED INC DE X X 10/30/03 ABN AMRO MORT CORP MULTI CLASS MORT P DE X 10/01/03 ABN AMRO MORTGAGE CORP MULTI CLA MOR DE X 10/01/03 ACTION PRODUCTS INTERNATIONAL INC FL X X 10/29/03 ACTIVCARD CORP DE X X 10/30/03 ADVANCE AUTO... (U.S. Securities and Exchange Commission -- Digest)
September 26, 2003 issue (dig092603.txt) Jan 22, 2004
STATE 8K ITEM NO. NAME OF ISSUER CODE 1 2 3 4 5 6 7 8 9 10 11 12 13 DATE COMMENT ------------------------------------------------------------------------------------------------ ABINGTON BANCORP INC MA X X 09/25/03 ADVANCED MARKETING SERVICES INC DE X 09/24/03 AEP INDUSTRIES INC DE X 09/22/03 AGILYSYS INC OH X X 09/15/03 AMERICAN BIO MEDICA CORP NY X 09/23/03 AMERICAN BUSINESS FINANCIAL SERVICES DE X X 09/25/03 AMERICAN PHARMACEUTICAL PARTNERS INC DE X X 09/25/03 AMERICAS SENIOR FINANCIAL... (U.S. Securities and Exchange Commission -- Digest)
August 1, 2003 issue (dig080103.txt) Jan 22, 2004
STATE 8K ITEM NO. NAME OF ISSUER CODE 1 2 3 4 5 6 7 8 9 DATE COMMENT ------------------------------------------------------------------------------------ 7 ELEVEN INC TX X 07/31/03 724 SOLUTIONS INC X 07/30/03 8X8 INC /DE/ DE X X 07/29/03 ACCESS ANYTIME BANCORP INC DE X 07/31/03 ACE SECURITIES CORP DE X 07/15/03 ADC TELECOMMUNICATIONS INC MN X X X 07/30/03 ADVANCED POWER TECHNOLOGY INC 07/29/03 AFFILIATED COMPUTER SERVICES INC DE X X 07/29/03 AGL RESOURCES INC GA X 04/22/03 AGL RESOURCES INC... (U.S. Securities and Exchange Commission -- Digest)
November 21, 2003 issue (dig112103.txt) Jan 22, 2004
STATE 8K ITEM NO. NAME OF ISSUER CODE 1 2 3 4 5 6 7 8 9 10 11 12 13 DATE COMMENT ------------------------------------------------------------------------------------------------ 10CHARGE INC DE X 11/14/03 AAMES FINANCIAL CORP/DE DE X X 11/20/03 ADVANCE AUTO PARTS INC DE X X 11/20/03 ADVANCED MAGNETICS INC DE X 11/20/03 ADVANTA BUSINESS RECEIVABLES CORP X 11/20/03 AEROPOSTALE INC X X 11/20/03 AGILE SOFTWARE CORP DE X X 11/20/03 AKORN INC LA X X 11/06/03 ALABAMA POWER CO AL X X 11/14/03... (U.S. Securities and Exchange Commission -- Digest)
November 13, 2003 issue (dig111303.txt) Jan 22, 2004
STATE 8K ITEM NO. NAME OF ISSUER CODE 1 2 3 4 5 6 7 8 9 10 11 12 13 DATE COMMENT ------------------------------------------------------------------------------------------------ ACE COMM CORP MD X 11/05/03 ACE SECURITIES CORP HOME EQUITY LOAN DE X X 10/25/03 ACE SECURITIES CORP HOME EQUITY LOAN DE X X 10/25/03 AMEND ADA-ES INC CO X 11/06/03 ADOLOR CORP X X 11/05/03 ADVANCED POWER TECHNOLOGY INC X 11/06/03 AEGIS MTG LOAN ASSET BACKED CERTS SER NY X X 10/25/03 AEGIS MTG LOAN ASSET BACKED CERTS... (U.S. Securities and Exchange Commission -- Digest)
Inveresk Wraps Up Stock Sale, Including 1.5M Over-Allotment Nov 26, 2003
Inveresk Wraps Up Stock Sale, Including 1. CARY, NC - Inveresk Research Group, its stock selling at $22 (Local Tech Wire (press release)
Pozen Names Former Inversk Executive as Vice President Nov 24, 2003
CHAPEL HILL ' Pozen, a pharmaceutical company developing migraine therapies, has named former PharmaResearch President James Alexander, as senior vice president of product development. Most recently, Alexander was chief medical officer for Inveresk Research Group (Local Tech Wire (press release)
Pozen names VP of product development Nov 24, 2003
With two migraine drugs in position to hit the market in the next year, Chapel Hill-based Pozen Inc. announced Monday that it has hired former Inveresk and PharmaResearch Corp. executive Dr. W. James Alexander as senior vice president of product development. Alexander joins Pozen from Inveresk Research Group, where he was chief medical officer (Raleigh Triangle Business Journal, NC)
Inveresk offering priced at $200M Nov 20, 2003
Cary-based Inveresk Research Group Inc. on Thursday priced a public offering of 10 million shares of its common stock at a price of $20 per share. The offering comprises 9 million shares being offered by various selling stockholders and 1 million shares being offered by Inveresk, which announced the offering earlier this month but had not set the price at that time (Raleigh Triangle Business Journal, NC)
Inveresk, stockholders plan 10-million share offering Nov 7, 2003
Inveresk, stockholders plan 10 million share offering - 2003-11-07 - Triangle Business Journal. Inveresk, stockholders plan 10 million share offering (Raleigh Triangle Business Journal, NC)
Inveresk sees stock offering in November Nov 7, 2003
Research topics related to this story in the eLibrary news and magazine archives. CHICAGO, Nov 7 (Reuters) - Inveresk Research Group (nasdaq: IRGI - news - people), a drug-development services provider, on Friday said it plans a public offering of up to 10 million shares of common stock to be priced in late November and completed by early December (Forbes)
